Extracellular Vesicles in Atrial Fibrillation—State of the Art
Open Access
- 8 July 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (14) , 7591
Abstract
Extracellular vesicles are particles released from cells and delimited by a lipid bilayer. They have been widely studied, including extensive investigation in cardiovascular diseases. Many scientists have explored their role in atrial fibrillation. Patients suffering from atrial fibrillation have been evidenced to present altered levels of these particles as well as changed amounts of their contents such as micro-ribonucleic acids (miRs). Although many observations have been made so far, a large randomized clinical trial is needed to assess the previous findings. This review aims to thoroughly summarize current research regarding extracellular vesicles in atrial fibrillation.Keywords
This publication has 60 references indexed in Scilit:
- Do Atrial Differences in Endothelial Damage, Leukocyte and Platelet Activation, or Tissue Factor Activity Contribute to Chamber‐Specific Thrombogenic Status in Patients with Atrial Fibrillation?Journal of Cardiovascular Electrophysiology, 2013
- Microparticles in atrial fibrillation: A link between cell activation or apoptosis, tissue remodelling and thrombogenicityInternational Journal of Cardiology, 2013
- Cellular damage, platelet activation, and inflammatory response after pulmonary vein isolation: A randomized study comparing radiofrequency ablation with cryoablationHeart Rhythm, 2012
- Platelet activation and induction of tissue factor in acute and chronic atrial fibrillation: Involvement of mononuclear cell-platelet interactionThrombosis Research, 2011
- Increased serum levels of microvesicles in nonvalvular atrial fibrillation determinated by ELISA using a specific monoclonal antibody AD-1Clinica Chimica Acta, 2010
- Elevated platelet microparticle levels in valvular atrial fibrillationHematology, 2009
- Levels of Circulating Procoagulant Microparticles in Nonvalvular Atrial FibrillationThe American Journal of Cardiology, 2007
- Elevated Platelet Microparticle Levels in Nonvalvular Atrial FibrillationChest, 2007
- Quality of Life in Patients with Atrial Fibrillation: A Systematic ReviewThe American Journal of Medicine, 2006
- Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillationHeart Rhythm, 2005